Evidence map›Paper›PMID 33521133›Full record

ArticleBioMed research international2021

Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome.

Rui Han, Xiaoyun Gong, Yuejie Zhu, Xiaoran Liu, Yan Xia, Yuhong Huang, Meng Zhang, Yunian Zhang, Xiaolin La, Jianbing Ding

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rui Han *Department of Prenatal Diagnosis, Reproductive Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0003-4782-3998
Xiaoyun Gong *Department of Reproductive Assistance, Center for Reproductive Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0002-5893-3538
Yuejie ZhuDepartment of Reproductive Assistance, Center for Reproductive Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0002-6088-8991
Xiaoran LiuDepartment of Prenatal Diagnosis, Reproductive Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0002-7459-3852
Yan XiaDepartment of Prenatal Diagnosis, Reproductive Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0002-3448-4977
Yuhong HuangDepartment of Immunology, College of Basic Medicine, Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0003-0914-2737
Meng ZhangDepartment of Reproductive Assistance, Center for Reproductive Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0002-6834-3478
Yunian ZhangDepartment of Immunology, College of Basic Medicine, Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0002-3032-5020
Xiaolin LaDepartment of Reproductive Assistance, Center for Reproductive Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0002-9793-2853
Jianbing DingDepartment of Immunology, College of Basic Medicine, Xinjiang Medical University, Urumqi, 830011 Xinjiang, China.ORCID https://orcid.org/0000-0001-5506-7665
Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study is to investigate the relationship of programmed cell death 1 (PD-1; also known as PDCD1) and programmed death-1-ligand 1 (PD-L1; also known as CD274) single nucleotide polymorphisms (SNPs) with polycystic ovary syndrome (PCOS). This study enrolled 330 PCOS patients and 350 matched controls. ELISA was used to detect the PD-1 and PD-L1 levels in serum. SnaPshot genotyping was performed to analyze the PD-1 and PD-L1 genotyping. Linkage disequilibrium and haplotype of TagSNP loci of PD-1 and PD-L1 genes were also detected. The relationship of genotypes and alleles with PCOS was analyzed. The levels of PD-1 and PD-L1 in the serum of PCOS patients were significantly lower than those in the control group (

Indexed as

AllelesPolymorphism, Single NucleotideAdultB7-H1 AntigenFemaleGene FrequencyGenotypeHaplotypesHumansLinkage DisequilibriumPolycystic Ovary SyndromeProgrammed Cell Death 1 ReceptorYoung AdultB7-H1 AntigenCD274 protein, humanPDCD1 protein, humanProgrammed Cell Death 1 Receptor

Identifiers

PMID33521133
PMCPMC7817229
OpenAlexW3119594145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.